Metabolic response as assessed by 18F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee

Metabolic response as assessed by 18F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee

ABSTRACT Background Strategies to optimize management in rhabdomyosarcoma (RMS) include risk stratification to assign therapy aiming to minimize treatment morbidity yet improve outcomes. This analysis evaluated the relationship between complete metabolic response (CMR) as assessed by 18F‐fluorodeoxy...

Full description

Bibliographic Details
Main Authors: Douglas J. Harrison, Yueh‐Yun Chi, Jing Tian, Pooja Hingorani, Leo Mascarenhas, Geoffrey B. McCowage, Brenda J. Weigel, Rajkumar Venkatramani, Suzanne L. Wolden, Torunn I. Yock, David A. Rodeberg, Andrea A. Hayes‐Jordan, Lisa A. Teot, Sheri L. Spunt, William H. Meyer, Douglas S. Hawkins, Barry L. Shulkin, Marguerite T. Parisi
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Cancer Medicine
Subjects:
chemotherapy
complete metabolic response
maximum standard uptake value (SUVmax)
pediatric
positron emission tomography
rhabdomyosarcoma
Online Access:https://doi.org/10.1002/cam4.3667

Internet

https://doi.org/10.1002/cam4.3667

Similar Items